Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Vertex

Vertex 2024 speaker: gain insights from Alina Fedaseyenka's art for Synapse

The freelance concept artist will share her process at our live art event.

Creative Bloq

Vertex 2024 speaker: learn from artist Nana Dhebuadze's keyframe pipeline

The freelance concept artist will share her process at our live art event.

Creative Bloq

Vertex 2024 speaker: gain tips on meeting clients' demands from Andy Hammond

Maverick Media's creative director is one of the speakers at this year's event.

Creative Bloq

From analysis to the latest developments in health,
read the most diverse news in one place.

Jumpstart Your Portfolio With These 3 Biotech Stocks

The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading….

StockNews.com

Vertex 2024 speaker: learn from the fresh voice of art director Ibby Karim

Ibby will share experiences of working with big-name IPs at Vertex 2024.

Creative Bloq

Vertex 2024 speaker: Moog Gravett on cinematics and technical art

The award-winning creative director is a guest at Vertex 2024.

Creative Bloq

This Could Be the Next Blockbuster Drug Stock to Buy

Vertex Pharmaceuticals just released data from its experimental drug to relieve pain, with no risk of addiction and very few side effects. This opioid alternative could give Vertex - already a powerhouse in the cystic fibrosis segment - another blockbuster drug to add to its portfolio.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Vertex 2024 speaker: learn new art skills from creature designer Brynn Metheney

The Ghostbusters concept artist will be at Vertex 2024.

Creative Bloq

Why Investors Are Flocking to These 2 Medical Stocks

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

StockNews.com

What incentives do scientists have to study rare diseases? | Explained

Explore the cutting-edge research of three Breakthrough Prize laureates in Life Sciences, and the systemic issues that influence access to treatments for three diseases desperately looking for cures: Parkinson’s disease, cystic fibrosis, and cancer.

The Hindu

Promising new gene therapies for sickle cell are out of reach in countries where they're needed most

New gene therapies promise a cure for sickle cell disease but experts say they are out of reach in places that need them the most

The Independent UK

The Guardian view on cystic fibrosis treatments: a rollercoaster ride for the sick

Editorial: Patients are facing shorter lives as drug companies are demanding prices that health services here and in other countries cannot pay

The Guardian - UK

Vertex 2024 tickets now on sale!

VFX, game art, animation and more – grab your tickets to 2024's ultimate new event for the CG art community.

Creative Bloq

The world's 1st CRISPR therapy has just been approved. Here's everything you need to know

U.K. regulators have approved the use of a CRISPR therapy called Casgevy to treat two inherited blood disorders. But what is it and how does it work?

LiveScience

Get all your
news in one place.

100’s of premium titles.
One news app.

Creative Bloq

Vertex, the ultimate event for 2D and 3D artists, returns in 2024

The Vertex festival of digital art, VFX and animation is back in 2024.

Homes & Gardens

Whether you're after a lightweight cordless or a sturdy upright, this is how the Shark Stratos vs. Vertex vacuum lineups compare

This is the range that takes the top spot in 2025

The Independent UK

‘Life-changing’ cystic fibrosis drugs approved for use in younger children

Campaigners welcomed the announcement by the Medicines and Healthcare Products Regulatory Agency.

Guitar World

“We all loved Larry Carlton’s guitar, it was just magic… We were all looking for guitars with chunky necks, to try and get the sustain that he had”: Session legend Dean Parks reveals the secrets of his most iconic Steely Dan and Eric Clapton guitar parts

You can hear Parks on Josie, Haitian Divorce, Change the World, Rikki Don’t Lose That Number and innumerable other songs – here, the guitarist unpacks the gear and recording sessions that forged them

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Best military watches for no-nonsense aesthetics, durability and practicality

Whether you’re a soldier or a civvie, these timepieces are built for any situation

Zenger

A Middle Age Woman Copes With Cystic Fibrosis As She Prays For A Miracle

Vertexs has been present in South Africa as the young patient copes with the high cost of the medication.

Fortune

Decentralized exchange Vertex launches on Arbitrum with backing from Jane Street and Hudson River Trading

The new, self-custodial DEX will offer high-speed spot and derivatives trading.

StockNews.com

3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

StockNews.com

The No. 1 Biotech Stock to Buy for 2023

Biotech stock Vertex Pharmaceuticals (VRTX) outperformed its industry peers, gaining more than 30% over the past year. The company reported solid performance in the CF business and across the company in the last quarter. Moreover, VRTX is committed to delivering a diversified pipeline of transformative medicines and therapies. Hence, this…

StockNews.com

3 Stocks to Buy With Rising Recession and Rate Risk

The stock market continues to be a challenging environment with rising rates a potent headwind. So far, the economy has been stable enough so that earnings growth has not contracted, but this is unlikely to persist the longer the Fed stays hawkish. This article discusses characteristics of stocks that are…

StockNews.com

3 Stocks to Ride the Bear Market Rally

Stocks could be embarking on another bear market rally despite a plethora of challenges. One factor is we are entering a seasonally bullish period of the year. Another is the bullish technical setup following the undercut and recovery of the mid-June lows. 3 stocks that investors should consider buying to…

1 2 3 4 5

People

Mangeet Kaur BounsMangeet

Jaimini DesaiJaimini Desai

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.